ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
0.00%
Dow Jones
38,852.86
-0.55%
Gold vs US Dollar
2,354.935
-0.19%
Brent Oil
84.255
-0.08%
Bitcoin
68,260.71
-0.04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kalvista Pharmaceuticals (MM) (CBYL)

  7. Kalvista Pharmaceuticals (MM) (CBYL) News

CARBYLAN THERAPEUTICS, INC. (CBYL)

Kalvista Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBYL
DateTimeSourceHeadlineSymbolCompany
30/11/201621:25Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/11/201621:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201622:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201618:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201621:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201621:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
21/11/201621:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
08/11/201621:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
04/11/201620:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/10/201611:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
26/10/201621:17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201621:59Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201621:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/09/201612:53PR Newswire (US)Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan...NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/09/201618:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/08/201611:02Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/08/201621:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
29/07/201621:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/06/201621:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
27/06/201622:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/06/201622:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:00GlobeNewswire Inc.Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed TransactionNASDAQ:CBYLKalvista Pharmaceuticals (MM)
17/06/201611:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201612:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201612:51Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CBYL

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
ZPHR
Zephyr Energy
LSE
AAU
Ariana Resources
LSE
AAZ
Anglo Asian Mining
LSE
TERN
Tern
LSE
BIRD
Blackbird
LSE
BARC
Barclays
LSE
BOO
Boohoo
LSE
GGP
Greatland Gold
LSE
LLOY
Lloyds Banking
LSE
QED
Quadrise
LSE
LBE
Longboat Energy
LSE
UKOG
Uk Oil & Gas
LSE
HE1
Helium One Global
LSE
I3E
I3 Energy
LSE
FCH
Funding Circle
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved